**GROSS MARGIN approx. 77%
**SG&A approx. 27%
**R&D approx. 17%
Net Interest / Other approx. 60
TAX RATE - GAAP approx. 30%
*TAX RATE - NON-GAAP approx. 31%
GENZ GAAP EPS approx. $2.65
AMORTIZATION approx. $0.55
FAS123 EXPENSE approx. $0.60
CONTINGENT CONVERTIBLE DEBT approx. $0.10
**GENZ NON-GAAP EPS $3.90
***WTD AVERAGE SHARES O/S approx. 274
CAPITAL EXPENDITURES approx. $500
This financial guidance, which is provided as part of a press release
dated April 21, 2008, is subject to all of the qualifications and
limitations described therein. Actual results may differ from these
forward-looking statements due to the numerous factors described in the
* Non-GAAP tax rate excludes the impact of amortization, one-time events,
FAS123R expense and EITF 04-8.
**Non-GAAP excludes the impact of amortization, one-time events, FAS123R
expense and EITF 04-8.
***WTD Average Shares Outstanding excludes the impact of EITF 04-8.
|SOURCE Genzyme Corp.|
Copyright©2008 PR Newswire.
All rights reserved